Address	Lunastigen 7 Huddinge AB 141 44 Sweden
Employees	-
Website	http://www.medivir.com
Updated	07/08/2019
Medivir AB engages in the development of pharmaceuticals products. It focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipeline such as remetinostat, birinapant, MV-818, and MIV-711 projects; and partnership pipeline which covers xerclear and MIV-802 project.